MSN - Profile
✉ Email this page to a colleague
Drugs and US Patents for MSN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | RIOCIGUAT | riociguat | TABLET;ORAL | 211135-004 | Sep 1, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 215364-001 | Aug 4, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 215113-005 | Jun 24, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | DOFETILIDE | dofetilide | CAPSULE;ORAL | 213220-001 | Jan 29, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |